Optimal control in combination therapy for heterogeneous cell populations with drug synergies
Cell heterogeneity plays an important role in patient responses to drug treatments. In many cancers, it is associated with poor treatment outcomes. Many modern drug combination therapies aim to exploit cell heterogeneity, but determining how to optimise responses from heterogeneous cell populations while accounting for multi-drug synergies remains a challenge. In this work, we introduce and analyse a general optimal control framework that can be used to model the treatment response of multiple cell populations that are treated with multiple drugs that mutually interact. In this framework, we model the effect of multiple drugs on the cell populations using a system of coupled semi-linear ordinary differential equations and derive general results for the optimal solutions. We then apply this framework to three canonical examples and discuss the wider question of how to relate mathematical optimality to clinically observable outcomes, introducing a systematic approach to propose qualitatively different classes of drug dosing inspired by optimal control.
Code (1)
Similar Papers 제목 키워드 기반
Dynamic Control of Stochastic Evolution: A Deep Reinforcement Learning Approach to Adaptively Targeting Emergent Drug Resistance
The challenge in controlling stochastic systems in which low-probability events can set the system on catastrophic trajectories is to develop a robust ability to respond to such events without significantly compromising …
Deep Reinforcement LearningReinforcement LearningOpportunities of Hybrid Model-based Reinforcement Learning for Cell Therapy Manufacturing Process Control
Driven by the key challenges of cell therapy manufacturing, including high complexity, high uncertainty, and very limited process observations, we propose a hybrid model-based reinforcement learning (RL) to efficiently g…
Decision MakingModel-based Reinforcement LearningReinforcement Learning (RL)Stochastic OptimizationA Dual Approach for Positive T-S Fuzzy Controller Design and Its Application to Cancer Treatment Under Immunotherapy and Chemotherapy
This study proposes an effective positive control design strategy for cancer treatment by resorting to the combination of immunotherapy and chemotherapy. The treatment objective is to transfer the initial number of tumor…
Study of dose-dependent combination immunotherapy using engineered T cells and IL-2 in cervical cancer
Adoptive T cell based immunotherapy is gaining significant traction in cancer treatment. Despite its limited success, so far, in treating solid cancers, it is increasingly successful, demonstrating to have a broader ther…
Nonlinear dynamics of CAR-T cell therapy
Chimeric antigen receptor T-cell (CAR-T) therapy is considered a promising cancer treatment. The dynamic response to this therapy can be broadly divided into a short-term phase, ranging from weeks to months, and a long-t…